Skopek T R, Recio L, Simpson D, Dallaire L, Melancon S B, Ogier H, O'Neill J P, Falta M T, Nicklas J A, Albertini R J
Chemical Industry Institute of Toxicology, Research Triangle Park, NC 27709.
Hum Genet. 1990 Jun;85(1):111-6. doi: 10.1007/BF00276334.
The frequency of hprt mutants in peripheral blood T-lymphocytes of two putative Lesch-Nyhan individuals and their parents was determined by a cell cloning assay to quantify the frequency of thioguanine-resistant mutants. The results confirmed the Lesch-Nyhan diagnosis and demonstrated that the mother has an elevated mutant frequency consistent with being heterozygous for an hprt mutation. Mass cultures of T-lymphocytes from both the children and their mother, as well as cultures of hprt mutant clones from the mother, were employed as sources of mRNA for cDNA sequence analysis. These hprt mutants show a single base substitution (T----C transition) at position 170 (exon 3). The predicted amino acid change is the substitution of threonine for methionine56. We have designated this new Lesch-Nyhan mutation hprtMontreal. The use of T-lymphocyte cultures allows rapid sequence analyses of hprt mutations, as well as family studies to define the origin of a particular mutation.
通过细胞克隆试验测定了两名疑似莱施-奈恩综合征患者及其父母外周血T淋巴细胞中次黄嘌呤-鸟嘌呤磷酸核糖转移酶(hprt)突变体的频率,以量化硫鸟嘌呤抗性突变体的频率。结果证实了莱施-奈恩综合征的诊断,并表明母亲的突变频率升高,这与她为hprt突变的杂合子一致。来自孩子及其母亲的T淋巴细胞大规模培养物,以及来自母亲的hprt突变体克隆培养物,都被用作cDNA序列分析的mRNA来源。这些hprt突变体在第170位(外显子3)显示出单个碱基替换(T→C转换)。预测的氨基酸变化是苏氨酸取代甲硫氨酸56。我们将这个新的莱施-奈恩综合征突变命名为hprt蒙特利尔。使用T淋巴细胞培养物可以快速进行hprt突变的序列分析,以及进行家族研究以确定特定突变的起源。